Hepatitis C Virus Pathogen Associated Molecular Pattern (PAMP) Triggers Production of Lambda-Interferons by Human Plasmacytoid Dendritic Cells

PLoS Pathogens

Volumn 9, Issue 4, 2013, Pages

  Stone, Amy E L ^a,b   Giugliano, Silvia ^b   Schnell, Gretja ^c   Cheng, Linling ^b   Leahy, Katelyn F ^b   Golden Mason, Lucy ^a,b   Gale, Michael ^c   Rosen, Hugo R ^a,b,d  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11 ANTIGEN; CD123 ANTIGEN; CD209 ANTIGEN; CD45 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HERMES ANTIGEN; HLA DR ANTIGEN; INTERFERON REGULATORY FACTOR 9; INTERLEUKIN 29; JANUS KINASE; SMALL INTERFERING RNA; STAT1 PROTEIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

ARTICLE; CELL CULTURE; CELL FRACTIONATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE SILENCING; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INFECTION CONTROL; KINETICS; LIVER CELL CARCINOMA; NORMAL HUMAN; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VIRUS REPLICATION; WESTERN BLOTTING;

HEPATITIS C VIRUS;

EID: 84876849653     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003316     Document Type: Article

References (38)

1. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, et al. (2005) Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19-28.
2. Seth RB, Sun L, Chen ZJ, (2006) Antiviral innate immunity pathways. Cell Research 16: 141-147.
3. Swiecki M, Wang Y, Vermi W, Gilfillan S, Schreiber RD, et al. (2011) Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo. J Exp Med 208: 2367-2374.
4. Swiecki M, Gilfillan S, Vermi W, Wang Y, Colonna M, (2010) Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 33: 955-966.
5. Takeuchi O, Akira S, (2008) MDA5/RIG-I and virus recognition. Curr Opin Immunol 20: 17-22.
6. Rosen HR, (2011) Clinical practice. Chronic hepatitis C infection. N Engl J Med 364: 2429-2438.
7. Balagopal A, Thomas DL, Thio CL, (2010) IL28B and the control of hepatitis C virus infection. Gastroenterology 139: 1865-1876.
8. Wertheimer AM, Bakke A, Rosen HR, (2004) Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. Hepatology 40: 335-345.
9. Kanto T, Inoue M, Miyatake H, Sato A, Sakakibara M, et al. (2004) Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 190: 1919-1926.
10. Laporte J, Bain C, Maurel P, Inchauspe G, Agut H, et al. (2003) Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. Blood 101: 52-57.
11. Kumagai Y, Kumar H, Koyama S, Kawai T, Takeuchi O, et al. (2009) Cutting Edge: TLR-Dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells. J Immunol 182: 3960-3964.
12. Takahashi K, Asabe S, Wieland S, Garaigorta U, Gastaminza P, et al. (2010) Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc Natl Acad Sci U S A 107: 7431-7436.
13. Takahashi K, Asabe S, Wieland S, Garaigorta U, Gastaminza P, et al. (2010) Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proceedings of the National Academy of Sciences of the United States of America 107: 7431-7436.
14. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401.
15. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, et al. (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461: 798-801.
16. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M Jr, (2008) Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454: 523-527.
17. Chaperot L, Blum A, Manches O, Lui G, Angel J, et al. (2006) Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J Immunol 176: 248-255.
18. Hu J, Nistal-Villan E, Voho A, Ganee A, Kumar M, et al. (2010) A common polymorphism in the caspase recruitment domain of RIG-I modifies the innate immune response of human dendritic cells. J Immunol 185: 424-432.
19. Munir S, Saleem S, Idrees M, Tariq A, Butt S, et al. (2010) Hepatitis C treatment: current and future perspectives. Virol J 7: 296.
20. Horner SM, Gale M Jr, (2009) Intracellular innate immune cascades and interferon defenses that control hepatitis C virus. Journal of Interferon and Cytokine Research 29: 489-498.
21. Kristiansen H, Scherer CA, McVean M, Iadonato SP, Vends S, et al. (2010) Extracellular 2′-5′ oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity. J Virol 84: 11898-11904.
22. Malathi K, Dong B, Gale M Jr, Silverman RH, (2007) Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: 816-819.
23. Zhou A, Molinaro RJ, Malathi K, Silverman RH, (2005) Mapping of the human RNASEL promoter and expression in cancer and normal cells. Journal of Interferon and Cytokine Research 25: 595-603.
24. Uzri D, Gehrke L, (2009) Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities. J Virol 83: 4174-4184.
25. Sioud M, (2006) Innate sensing of self and non-self RNAs by Toll-like receptors. Trends Mol Med 12: 167-176.
26. Boonstra A, van der Laan LJ, Vanwolleghem T, Janssen HL, (2009) Experimental models for hepatitis C viral infection. Hepatology 50: 1646-1655.
27. Thomas E, Gonzalez VD, Li Q, Modi AA, Chen W, et al. (2012) HCV Infection Induces a Unique Hepatic Innate Immune Response Associated With Robust Production of Type III Interferons. Gastroenterology 142: 978-988.
28. Bandi P, Pagliaccetti NE, Robek MD, (2010) Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteins. Journal of Interferon and Cytokine Research 30: 123-134.
29. Lande R, Gilliet M, (2010) Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses. Annals of the New York Academy of Sciences 1183: 89-103.
30. Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A, (2001) Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 31: 3388-3393.
31. Doerfler ME, Danner RL, Shelhamer JH, Parrillo JE, (1989) Bacterial lipopolysaccharides prime human neutrophils for enhanced production of leukotriene B4. Journal of Clinical Investigation 83: 970-977.
32. Aderem AA, Cohen DS, Wright SD, Cohn ZA, (1986) Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. J Exp Med 164: 165-179.
33. Eisenacher K, Steinberg C, Reindl W, Krug A, (2007) The role of viral nucleic acid recognition in dendritic cells for innate and adaptive antiviral immunity. Immunobiology 212: 701-714.
34. Osterlund PI, Pietila TE, Veckman V, Kotenko SV, Julkunen I, (2007) IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J Immunol 179: 3434-3442.
35. Robek MD, Boyd BS, Chisari FV, (2005) Lambda interferon inhibits hepatitis B and C virus replication. J Virol 79: 3851-3854.
36. Diegelmann J, Beigel F, Zitzmann K, Kaul A, Goke B, et al. (2010) Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus. PLoS One 5: e15200.
37. Rehwinkel J, Tan CP, Goubau D, Schulz O, Pichlmair A, et al. (2010) RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140: 397-408.
38. Zhu H, Butera M, Nelson DR, Liu C, (2005) Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication. Virol J 2: 80.